help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosen, L. B.
Right arrow Articles by Adler, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosen, L. B.
Right arrow Articles by Adler, G. K.

Endocrinology, Vol 130, 2237-2244, Copyright © 1992 by Endocrine Society


ARTICLES

Effects of glucocorticoid on corticotropin-releasing hormone gene regulation by second messenger pathways in NPLC and AtT-20 cells

LB Rosen, JA Majzoub and GK Adler
Department of Medicine, Children's Hospital, Boston, Massachusetts.

We have examined the regulation of the hypothalamic secretagogue CRH by glucocorticoid and the protein kinase-A and -C second messenger pathways in cultured cells. We show that the human primary liver carcinoma NPLC expresses the endogenous CRH gene. Dexamethasone reduced CRH mRNA levels by more than 90%, with half-maximal suppression at 5 nM. Phorbol ester treatment to activate the protein kinase-C pathway increased CRH mRNA levels up to 30-fold, whereas forskolin treatment to activate the protein kinase-A pathway had no effect. In coincubation experiments, dexamethasone completely suppressed phorbol ester-induced CRH mRNA levels in NPLC cells, maintaining them at the levels seen in untreated cells. We contrasted this regulation with the effects of glucocorticoid on CRH mRNA induction by forskolin in R1, a mouse anterior pituitary cell line (AtT-20) stably transfected with the human CRH gene. Dexamethasone suppressed forskolin-induced CRH mRNA levels by 70% in R1 cells, but only to levels that were still 10-fold greater than those in untreated cells. These results suggest that CRH induction in vivo by ligands that act via protein kinase-A may be less effectively suppressed by glucocorticoid feedback than CRH induction by ligands that act via protein kinase-C. This differential effect of glucocorticoid on CRH mRNA regulation could help explain the abnormal CRH production observed in clinical disorders such as anorexia nervosa and major depression.


This article has been cited by other articles:


Home page
EndocrinologyHome page
M. Yao, J. Schulkin, and R. J. Denver
Evolutionarily Conserved Glucocorticoid Regulation of Corticotropin-Releasing Factor Expression
Endocrinology, May 1, 2008; 149(5): 2352 - 2360.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
E. W. Hillhouse and D. K. Grammatopoulos
The Molecular Mechanisms Underlying the Regulation of the Biological Activity of Corticotropin-Releasing Hormone Receptors: Implications for Physiology and Pathophysiology
Endocr. Rev., May 1, 2006; 27(3): 260 - 286.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. L. Parham, S. Zervou, E. Karteris, R. D. Catalano, R. W. Old, and E. W. Hillhouse
Promoter Analysis of Human Corticotropin-Releasing Factor (CRF) Type 1 Receptor and Regulation by CRF and Urocortin
Endocrinology, August 1, 2004; 145(8): 3971 - 3983.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Chen, J. Vaughan, and W. W. Vale
Glucocorticoids Regulate the Expression of the Mouse Urocortin II Gene: A Putative Connection between the Corticotropin-Releasing Factor Receptor Pathways
Mol. Endocrinol., August 1, 2003; 17(8): 1622 - 1639.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. G. Watts and G. Sanchez-Watts
Interactions between Heterotypic Stressors and Corticosterone Reveal Integrative Mechanisms for Controlling Corticotropin-Releasing Hormone Gene Expression in the Rat Paraventricular Nucleus
J. Neurosci., July 15, 2002; 22(14): 6282 - 6289.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. J. Kovacs, A. Foldes, and P. E. Sawchenko
Glucocorticoid Negative Feedback Selectively Targets Vasopressin Transcription in Parvocellular Neurosecretory Neurons
J. Neurosci., May 15, 2000; 20(10): 3843 - 3852.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y.-H. Cheng, R. C. Nicholson, B. King, E.-C. Chan, J. T. Fitter, and R. Smith
Glucocorticoid Stimulation of Corticotropin-Releasing Hormone Gene Expression Requires a Cyclic Adenosine 3',5'-Monophosphate Regulatory Element in Human Primary Placental Cytotrophoblast Cells
J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1937 - 1945.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
Y.-H. Cheng, R. C. Nicholson, B. King, E.-C. Chan, J. T. Fitter, and R. Smith
Corticotropin-Releasing Hormone Gene Expression in Primary Placental Cells Is Modulated by Cyclic Adenosine 3',5'-Monophosphate
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1239 - 1244.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society